Atossa Therapeutics, Inc. has announced plans for a new Phase 3 clinical trial, SMART 2.0, which will explore the effectiveness of oral (Z)-endoxifen in reducing interval breast cancer among high-risk ...
Smart rings may have certain advantages over wrist-worn devices, but we recommend you do not throw out your smartwatch just yet. When you purchase through links on our site, we may earn an affiliate ...
Honest John on MSN
First shots of the 2026 Smart #2 revealed
All we know so far is that the Smart #2 will be revealed in full towards the end of 2026. No prices have been announced yet, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback